OBJECTIVES: The incidence and mortality rates from primary hepatocellular carcinoma (HCC) are higher in black Americans compared to whites. The goal of this study was to determine if there are racial disparities in HCC stage at diagnosis and treatment. METHODS: We compared patient age, tumor stage, rates of surgical intervention and survival in black (n=1718) and white (n=9752) HCC cases between 1992 and 2001 in the Surveillance, Epidemiology and End Results (SEER)-11 + Alaska database. RESULTS: Black HCC cases were significantly younger at diagnosis (p < 0.0001). Black cases were more likely to have regional and distant metastasis at presentation (p < 0.0005) and were less likely to have surgery performed (p < 0.001). The racial difference in surgery treatment was significant among patients with localized (p = 0.001) and regional (p = 0.012) HCC, but not with distant HCC. Overall survival rates were lower in blacks (p = 0.0033). Survival was similar in blacks and whites with regional and distant disease. Yet, among patients with localized HCC, survival rates were lower in blacks (p = 0.0030). CONCLUSIONS: Black HCC patients have more advanced tumor stage at diagnosis and lower rates of both surgical intervention and survival. The racial disparities in surgical treatment utilization and survival were most striking between black and white HCC patients with localized HCC.
OBJECTIVES: The incidence and mortality rates from primary hepatocellular carcinoma (HCC) are higher in black Americans compared to whites. The goal of this study was to determine if there are racial disparities in HCC stage at diagnosis and treatment. METHODS: We compared patient age, tumor stage, rates of surgical intervention and survival in black (n=1718) and white (n=9752) HCC cases between 1992 and 2001 in the Surveillance, Epidemiology and End Results (SEER)-11 + Alaska database. RESULTS: Black HCC cases were significantly younger at diagnosis (p < 0.0001). Black cases were more likely to have regional and distant metastasis at presentation (p < 0.0005) and were less likely to have surgery performed (p < 0.001). The racial difference in surgery treatment was significant among patients with localized (p = 0.001) and regional (p = 0.012) HCC, but not with distant HCC. Overall survival rates were lower in blacks (p = 0.0033). Survival was similar in blacks and whites with regional and distant disease. Yet, among patients with localized HCC, survival rates were lower in blacks (p = 0.0030). CONCLUSIONS: Black HCC patients have more advanced tumor stage at diagnosis and lower rates of both surgical intervention and survival. The racial disparities in surgical treatment utilization and survival were most striking between black and white HCC patients with localized HCC.
Authors: Adrian M Di Bisceglie; Andre C Lyra; Myron Schwartz; Rajender K Reddy; Paul Martin; Gregory Gores; Anna S F Lok; Khozema B Hussain; Robert Gish; David H Van Thiel; Zobair Younossi; Myron Tong; Tarek Hassanein; Luis Balart; Jacquelyn Fleckenstein; Stephen Flamm; Andres Blei; Alex S Befeler Journal: Am J Gastroenterol Date: 2003-09 Impact factor: 10.864
Authors: Amit G Singal; Akbar K Waljee; Nishant Patel; Emerson Y Chen; Jasmin A Tiro; Jorge A Marrero; Adam C Yopp Journal: J Natl Compr Canc Netw Date: 2013-09-01 Impact factor: 11.908
Authors: Christopher J Sonnenday; Justin B Dimick; Richard D Schulick; Michael A Choti Journal: J Gastrointest Surg Date: 2007-10-03 Impact factor: 3.452
Authors: Nicole E Rich; Caitlin Hester; Mobolaji Odewole; Caitlin C Murphy; Neehar D Parikh; Jorge A Marrero; Adam C Yopp; Amit G Singal Journal: Clin Gastroenterol Hepatol Date: 2018-05-31 Impact factor: 11.382
Authors: Alexis P Chidi; Cindy L Bryce; Larissa Myaskovsky; Michael J Fine; David A Geller; Douglas P Landsittel; Allan Tsung Journal: Ann Surg Date: 2016-02 Impact factor: 12.969